{
  "exportInfo": {
    "timestamp": "2025-06-12T14:01:08.127986",
    "tool": "Stock Signals Analyzer",
    "version": "2.0"
  },
  "stockData": {
    "address1": "642 Newtown Yardley Road",
    "address2": "Suite 100",
    "city": "Newtown",
    "state": "PA",
    "zip": "18940",
    "country": "United States",
    "phone": "215 944 6100",
    "website": "https://heliusmedical.com",
    "industry": "Medical Devices",
    "industryKey": "medical-devices",
    "industryDisp": "Medical Devices",
    "sector": "Healthcare",
    "sectorKey": "healthcare",
    "sectorDisp": "Healthcare",
    "longBusinessSummary": "Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.",
    "fullTimeEmployees": 21,
    "companyOfficers": [
      {
        "maxAge": 1,
        "name": "Mr. Dane Carl Andreeff",
        "age": 58,
        "title": "President, CEO & Director",
        "yearBorn": 1966,
        "fiscalYear": 2024,
        "totalPay": 586659,
        "exercisedValue": 0,
        "unexercisedValue": 0
      },
      {
        "maxAge": 1,
        "name": "Dr. Antonella  Favit-Van Pelt M.D., Ph.D.",
        "age": 56,
        "title": "Chief Medical Officer",
        "yearBorn": 1968,
        "fiscalYear": 2024,
        "totalPay": 521386,
        "exercisedValue": 0,
        "unexercisedValue": 0
      },
      {
        "maxAge": 1,
        "name": "Mr. Lawrence  Picciano",
        "title": "Senior Vice President of Engineering, Quality & Regulatory Affairs",
        "fiscalYear": 2024,
        "exercisedValue": 0,
        "unexercisedValue": 0
      }
    ],
    "compensationAsOfEpochDate": 1735603200,
    "executiveTeam": [],
    "maxAge": 86400,
    "priceHint": 4,
    "previousClose": 0.845,
    "open": 1.45,
    "dayLow": 1.0401,
    "dayHigh": 1.85,
    "regularMarketPreviousClose": 0.845,
    "regularMarketOpen": 1.45,
    "regularMarketDayLow": 1.0401,
    "regularMarketDayHigh": 1.85,
    "payoutRatio": 0.0,
    "beta": 1.13,
    "forwardPE": -0.46058092,
    "volume": 143518716,
    "regularMarketVolume": 143518716,
    "averageVolume": 3259636,
    "averageVolume10days": 20459790,
    "averageDailyVolume10Day": 20459790,
    "bid": 1.07,
    "ask": 1.75,
    "bidSize": 2,
    "askSize": 9,
    "marketCap": 586097,
    "fiftyTwoWeekLow": 0.753,
    "fiftyTwoWeekHigh": 24.0,
    "priceToSalesTrailing12Months": 1.350454,
    "fiftyDayAverage": 4.06758,
    "twoHundredDayAverage": 7.758495,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "tradeable": false,
    "enterpriseValue": -522851,
    "profitMargins": 0.0,
    "floatShares": 289885,
    "sharesOutstanding": 528016,
    "sharesShort": 62031,
    "sharesShortPriorMonth": 1414,
    "sharesShortPreviousMonthDate": 1745971200,
    "dateShortInterest": 1748563200,
    "sharesPercentSharesOut": 0.1175,
    "heldPercentInsiders": 0.05745,
    "heldPercentInstitutions": 0.0049900003,
    "shortRatio": 1.98,
    "shortPercentOfFloat": 0.1175,
    "impliedSharesOutstanding": 542549,
    "bookValue": 3.134,
    "priceToBook": 0.35417995,
    "lastFiscalYearEnd": 1735603200,
    "nextFiscalYearEnd": 1767139200,
    "mostRecentQuarter": 1743379200,
    "netIncomeToCommon": -13064000,
    "trailingEps": -26.4,
    "forwardEps": -2.41,
    "lastSplitFactor": "1:15",
    "lastSplitDate": 1746144000,
    "enterpriseToRevenue": -1.205,
    "enterpriseToEbitda": 0.036,
    "52WeekChange": -0.93018866,
    "SandP52WeekChange": 0.10830474,
    "quoteType": "EQUITY",
    "currentPrice": 1.11,
    "recommendationMean": 3.0,
    "recommendationKey": "hold",
    "totalCash": 1109000,
    "totalCashPerShare": 2.1,
    "ebitda": -14406000,
    "totalDebt": 0,
    "quickRatio": 0.804,
    "currentRatio": 1.69,
    "totalRevenue": 434000,
    "revenuePerShare": 1.481,
    "returnOnAssets": -1.95569,
    "returnOnEquity": -8.0,
    "grossProfits": -146000,
    "freeCashflow": -6167625,
    "operatingCashflow": -11576000,
    "revenueGrowth": -0.637,
    "grossMargins": -0.33641,
    "ebitdaMargins": 0.0,
    "operatingMargins": -81.85714,
    "financialCurrency": "USD",
    "symbol": "HSDT",
    "language": "en-US",
    "region": "US",
    "typeDisp": "Equity",
    "quoteSourceName": "Nasdaq Real Time Price",
    "triggerable": true,
    "customPriceAlertConfidence": "HIGH",
    "regularMarketChangePercent": 31.3609,
    "regularMarketPrice": 1.11,
    "shortName": "Helius Medical Technologies, In",
    "longName": "Helius Medical Technologies, Inc.",
    "hasPrePostMarketData": true,
    "firstTradeDateMilliseconds": 1403875800000,
    "preMarketChange": -0.43940002,
    "preMarketChangePercent": -39.585587,
    "preMarketPrice": 0.6706,
    "regularMarketChange": 0.265,
    "regularMarketDayRange": "1.0401 - 1.85",
    "fullExchangeName": "NasdaqCM",
    "averageDailyVolume3Month": 3259636,
    "fiftyTwoWeekLowChange": 0.357,
    "fiftyTwoWeekLowChangePercent": 0.47410357,
    "fiftyTwoWeekRange": "0.753 - 24.0",
    "fiftyTwoWeekHighChange": -22.89,
    "fiftyTwoWeekHighChangePercent": -0.95374995,
    "fiftyTwoWeekChangePercent": -93.01887,
    "dividendDate": 1609718400,
    "earningsTimestamp": 1746129600,
    "earningsTimestampStart": 1754909940,
    "earningsTimestampEnd": 1755259200,
    "earningsCallTimestampStart": 1723494600,
    "earningsCallTimestampEnd": 1723494600,
    "isEarningsDateEstimate": true,
    "epsTrailingTwelveMonths": -26.4,
    "epsForward": -2.41,
    "fiftyDayAverageChange": -2.95758,
    "fiftyDayAverageChangePercent": -0.72711045,
    "twoHundredDayAverageChange": -6.6484947,
    "twoHundredDayAverageChangePercent": -0.856931,
    "sourceInterval": 15,
    "exchangeDataDelayedBy": 0,
    "averageAnalystRating": "3.0 - Hold",
    "cryptoTradeable": false,
    "corporateActions": [],
    "preMarketTime": 1749729666,
    "regularMarketTime": 1749672001,
    "exchange": "NCM",
    "messageBoardId": "finmb_266639642",
    "exchangeTimezoneName": "America/New_York",
    "exchangeTimezoneShortName": "EDT",
    "gmtOffSetMilliseconds": -14400000,
    "market": "us_market",
    "esgPopulated": false,
    "marketState": "PRE",
    "displayName": "Helius Medical",
    "trailingPegRatio": null
  },
  "analysisResults": {
    "symbol": "HSDT",
    "totalScore": 7.35,
    "maxPossibleScore": 89.3175,
    "categoryResults": {
      "corporateTransformation": {
        "name": "Corporate Transformation & Strategic Pivots",
        "description": "Business model changes and transformational events - highest impact signals",
        "weight": 0.3,
        "score": 24.5,
        "maxScore": 92.75,
        "signals": [
          {
            "name": "Defense/Government Transformation",
            "description": "Pivot to defense sector - NUKK pattern (5535% surge)",
            "triggered": false,
            "score": 0,
            "maxScore": 100,
            "details": [],
            "conditions": [
              {
                "condition": "defense sector acquisition OR government contract award > $10M",
                "met": false,
                "score": 75,
                "description": "Initial defense sector entry"
              },
              {
                "condition": "defense acquisition > marketCap * 0.5 OR Iron Dome/critical infrastructure",
                "met": false,
                "score": 95,
                "description": "Transformational defense pivot - NUKK pattern"
              },
              {
                "condition": "NATO/DOD approved vendor status OR $100M+ government contracts",
                "met": false,
                "score": 100,
                "description": "Full defense sector validation"
              }
            ]
          },
          {
            "name": "Biotech/AI Transformation Catalyst",
            "description": "High-multiple sector pivot opportunities",
            "triggered": true,
            "score": 70,
            "maxScore": 90,
            "details": [
              "Significant high-tech transformation"
            ],
            "conditions": [
              {
                "condition": "biotech/AI acquisition OR licensing deal > marketCap * 0.3",
                "met": true,
                "score": 70,
                "description": "Significant high-tech transformation"
              },
              {
                "condition": "FDA-approved platform OR breakthrough AI technology",
                "met": false,
                "score": 90,
                "description": "Validated technology transformation"
              }
            ]
          },
          {
            "name": "Float Compression Mechanics",
            "description": "Reverse split creating volatility amplification - NUKK/HSDT pattern",
            "triggered": false,
            "score": 0,
            "maxScore": 85,
            "details": [],
            "conditions": [
              {
                "condition": "reverse split ratio >= 8:1 AND post-split float < 10M shares",
                "met": false,
                "score": 60,
                "description": "Significant float compression"
              },
              {
                "condition": "reverse split AND catalyst within 90 days AND float < 5M",
                "met": false,
                "score": 85,
                "description": "NUKK-style volatility amplification setup"
              }
            ]
          }
        ],
        "normalizedScore": 26.41509433962264
      },
      "clinicalAndRegulatory": {
        "name": "Clinical Excellence & Regulatory Milestones",
        "description": "FDA approvals, clinical superiority, and regulatory catalysts",
        "weight": 0.25,
        "score": 0.0,
        "maxScore": 93.0,
        "signals": [
          {
            "name": "Head-to-Head Clinical Superiority",
            "description": "Beating established standard of care - SMMT pattern",
            "triggered": false,
            "score": 0,
            "maxScore": 95,
            "details": [],
            "conditions": [
              {
                "condition": "statistically significant improvement vs standard of care",
                "met": false,
                "score": 70,
                "description": "Clinical superiority demonstrated"
              },
              {
                "condition": "49%+ improvement vs Keytruda/Opdivo OR first-in-class approval",
                "met": false,
                "score": 95,
                "description": "SMMT-level clinical breakthrough"
              }
            ]
          },
          {
            "name": "Reimbursement Critical Mass",
            "description": "3+ major payers approval - HSDT pattern (119% surge)",
            "triggered": false,
            "score": 0,
            "maxScore": 100,
            "details": [],
            "conditions": [
              {
                "condition": "2 major payers approve reimbursement (Anthem, Aetna, UHC, etc.)",
                "met": false,
                "score": 60,
                "description": "Reimbursement momentum building"
              },
              {
                "condition": "3+ major payers approve reimbursement within 6 months",
                "met": false,
                "score": 90,
                "description": "HSDT-style reimbursement tipping point"
              },
              {
                "condition": "CMS/Medicare approval OR national coverage determination",
                "met": false,
                "score": 100,
                "description": "Universal coverage catalyst"
              }
            ]
          },
          {
            "name": "FDA Accelerated Pathway Signals",
            "description": "Fast Track, Breakthrough, Orphan designations",
            "triggered": false,
            "score": 0,
            "maxScore": 80,
            "details": [],
            "conditions": [
              {
                "condition": "FDA Fast Track designation OR Breakthrough Therapy",
                "met": false,
                "score": 65,
                "description": "Accelerated regulatory pathway"
              },
              {
                "condition": "Orphan Drug designation with market exclusivity",
                "met": false,
                "score": 80,
                "description": "Protected market opportunity"
              }
            ]
          }
        ],
        "normalizedScore": 0.0
      },
      "technicalCompression": {
        "name": "Advanced Technical Pattern Recognition",
        "description": "Enhanced technical patterns based on DRUG surge analysis",
        "weight": 0.2,
        "score": 0.0,
        "maxScore": 86.5,
        "signals": [
          {
            "name": "DRUG-Pattern Bollinger Squeeze",
            "description": "Bollinger Band compression >30 days - DRUG 2000% pattern",
            "triggered": false,
            "score": 0,
            "maxScore": 95,
            "details": [],
            "conditions": [
              {
                "condition": "Bollinger Band width <5th percentile for 30+ days",
                "met": false,
                "score": 70,
                "description": "Significant volatility compression"
              },
              {
                "condition": "BB squeeze >45 days AND RSI <30 AND catalyst approaching",
                "met": false,
                "score": 95,
                "description": "DRUG-level coiled spring with catalyst"
              }
            ]
          },
          {
            "name": "Extended Oversold Recovery Pattern",
            "description": "RSI <30 with bullish divergence setup",
            "triggered": false,
            "score": 0,
            "maxScore": 85,
            "details": [],
            "conditions": [
              {
                "condition": "RSI <25 for 10+ days AND volume building",
                "met": false,
                "score": 55,
                "description": "Extreme oversold with accumulation"
              },
              {
                "condition": "RSI bullish divergence AND MACD convergence AND catalyst proximity",
                "met": false,
                "score": 85,
                "description": "Multi-indicator oversold reversal setup"
              }
            ]
          },
          {
            "name": "Extended Base Building Pattern",
            "description": "6+ month consolidation preceding breakout",
            "triggered": false,
            "score": 0,
            "maxScore": 75,
            "details": [],
            "conditions": [
              {
                "condition": "6+ month base building AND multiple support tests",
                "met": false,
                "score": 50,
                "description": "Solid foundation established"
              },
              {
                "condition": "NUKK-style 6-month $1.30-$2.00 base AND tightening volume",
                "met": false,
                "score": 75,
                "description": "Extended base with volume compression"
              }
            ]
          }
        ],
        "normalizedScore": 0.0
      },
      "volumeIntelligence": {
        "name": "Advanced Volume Pattern Analysis",
        "description": "Sophisticated volume patterns from successful surges",
        "weight": 0.15,
        "score": 0.0,
        "maxScore": 79.25,
        "signals": [
          {
            "name": "30-Day Pre-Surge Volume Building",
            "description": "Volume accumulation pattern from DRUG analysis",
            "triggered": false,
            "score": 0,
            "maxScore": 85,
            "details": [],
            "conditions": [
              {
                "condition": "volume >2x average for 5+ days in 30-day window",
                "met": false,
                "score": 60,
                "description": "Early accumulation pattern"
              },
              {
                "condition": "volume >3x average for 7+ days AND 13F filings increase",
                "met": false,
                "score": 85,
                "description": "Confirmed institutional accumulation"
              }
            ]
          },
          {
            "name": "Extreme Volume Explosion",
            "description": "VTAK-style volume surge (2,870% above average)",
            "triggered": false,
            "score": 0,
            "maxScore": 90,
            "details": [],
            "conditions": [
              {
                "condition": "volume >10x average AND float turnover >50%",
                "met": false,
                "score": 65,
                "description": "Significant volume surge"
              },
              {
                "condition": "volume >25x average AND float turnover >100%",
                "met": false,
                "score": 90,
                "description": "VTAK-level volume explosion"
              }
            ]
          },
          {
            "name": "Institutional Dark Pool Activity",
            "description": "Off-exchange volume indicating smart money",
            "triggered": false,
            "score": 0,
            "maxScore": 55,
            "details": [],
            "conditions": [
              {
                "condition": "dark pool ratio >35% for 5+ days",
                "met": false,
                "score": 55,
                "description": "Institutional accumulation signal"
              }
            ]
          }
        ],
        "normalizedScore": 0.0
      },
      "commercialValidation": {
        "name": "Commercial Breakthrough Signals",
        "description": "First sales, partnerships, and validation milestones",
        "weight": 0.07,
        "score": 0.0,
        "maxScore": 92.5,
        "signals": [
          {
            "name": "First Sale/Partnership Validation",
            "description": "VTAK-pattern first commercial order (173% surge)",
            "triggered": false,
            "score": 0,
            "maxScore": 90,
            "details": [],
            "conditions": [
              {
                "condition": "first commercial sale from recognized institution",
                "met": false,
                "score": 70,
                "description": "Initial commercial validation"
              },
              {
                "condition": "first sale from major hospital/university system",
                "met": false,
                "score": 90,
                "description": "VTAK-style validation milestone"
              }
            ]
          },
          {
            "name": "Massive Insider Investment",
            "description": "SMMT-pattern: $79M insider investment at market prices",
            "triggered": false,
            "score": 0,
            "maxScore": 95,
            "details": [],
            "conditions": [
              {
                "condition": "insider purchases >$10M at market price within 30 days",
                "met": false,
                "score": 75,
                "description": "Significant insider confidence"
              },
              {
                "condition": "insider purchases >$50M at market price (SMMT-style)",
                "met": false,
                "score": 95,
                "description": "SMMT-level insider conviction"
              }
            ]
          }
        ],
        "normalizedScore": 0.0
      },
      "microstructure": {
        "name": "Market Microstructure Amplifiers",
        "description": "Float dynamics and structural volatility factors",
        "weight": 0.03,
        "score": 0.0,
        "maxScore": 86.0,
        "signals": [
          {
            "name": "NUKK-Style Float Scarcity",
            "description": "Ultra-low float creating explosive potential",
            "triggered": false,
            "score": 0,
            "maxScore": 90,
            "details": [],
            "conditions": [
              {
                "condition": "float <3M shares AND market cap $5M-$50M",
                "met": false,
                "score": 75,
                "description": "DRUG-level volatility setup"
              },
              {
                "condition": "float <2.5M shares AND recent reverse split",
                "met": false,
                "score": 90,
                "description": "NUKK-level amplification potential"
              }
            ]
          },
          {
            "name": "Short Interest Dynamics",
            "description": "Short covering amplification factors",
            "triggered": false,
            "score": 0,
            "maxScore": 80,
            "details": [],
            "conditions": [
              {
                "condition": "short interest >20% AND days to cover >3",
                "met": false,
                "score": 55,
                "description": "Moderate squeeze potential"
              },
              {
                "condition": "short interest >50% AND limited borrows available",
                "met": false,
                "score": 80,
                "description": "High squeeze probability"
              }
            ]
          }
        ],
        "normalizedScore": 0.0
      }
    },
    "triggeredSignals": [
      {
        "category": "Corporate Transformation & Strategic Pivots",
        "signal": "Biotech/AI Transformation Catalyst",
        "score": 70,
        "description": "High-multiple sector pivot opportunities"
      }
    ],
    "missingDataFields": [
      "insiderOwnership",
      "institutionalOwnership"
    ],
    "scorePercentage": 8.229070450919473
  },
  "signalsConfig": {
    "metadata": {
      "version": "5.0",
      "lastUpdated": "2025-06-12",
      "description": "Revolutionary surge detection framework based on analysis of 15+ documented surges including NUKK (5535%), DRUG (2000%), VTAK (173%), HSDT (119%), SMMT (583%)",
      "author": "Enhanced Framework Based on Comprehensive Surge Document Analysis",
      "backtestedPeriod": "2020-2025",
      "documentedSurges": "NUKK, DRUG, VTAK, HSDT, SMMT, GME, AMC, INTZ, MNPR, ADAP, APP, NMAX, HCTI",
      "accuracyTarget": "65-72% (up from 58-62%)",
      "falsePositiveTarget": "10-12% (down from 14-16%)",
      "keyBreakthroughs": [
        "Defense pivot phenomenon identification (NUKK case study)",
        "Reimbursement tipping point detection (HSDT pattern)",
        "Bollinger Band compression >30 days (DRUG pattern)",
        "Progressive catalyst accumulation scoring",
        "Insider investment signals (SMMT pattern)",
        "Commercial validation milestones (VTAK pattern)",
        "Float compression amplification factors"
      ]
    },
    "marketStructureRequirements": {
      "description": "Refined pre-screening based on successful surge analysis",
      "optimalMarketCapBands": {
        "nanoCapExplosive": {
          "min": 500000,
          "max": 10000000,
          "surgeMultiplier": 5.0,
          "riskMultiplier": 4.0,
          "description": "Extreme volatility zone - NUKK/DRUG territory",
          "exampleSurges": [
            "NUKK: 5535%",
            "DRUG: 2000%",
            "HCTI: 250%"
          ]
        },
        "microCapPrime": {
          "min": 10000000,
          "max": 100000000,
          "surgeMultiplier": 3.0,
          "riskMultiplier": 2.0,
          "description": "Sweet spot for sustainable surges",
          "exampleSurges": [
            "VTAK: 173%",
            "HSDT: 119%"
          ]
        },
        "smallCapMomentum": {
          "min": 100000000,
          "max": 1000000000,
          "surgeMultiplier": 2.0,
          "riskMultiplier": 1.0,
          "description": "Institutional-friendly surge zone",
          "exampleSurges": [
            "SMMT: 583%",
            "MNPR: 522%"
          ]
        }
      },
      "floatRequirements": {
        "ultraLowFloat": {
          "max": 5000000,
          "volatilityMultiplier": 5.0,
          "description": "NUKK-level amplification",
          "riskNote": "Binary outcomes, extreme volatility"
        },
        "lowFloat": {
          "min": 5000000,
          "max": 20000000,
          "volatilityMultiplier": 3.0,
          "description": "Optimal surge potential"
        },
        "moderateFloat": {
          "min": 20000000,
          "max": 50000000,
          "volatilityMultiplier": 2.0,
          "description": "Sustainable momentum potential"
        }
      },
      "volumeRequirements": {
        "minimumDailyDollarVolume": 2000000,
        "surgeTriggerVolume": 5.0,
        "extremeSurgeVolume": 25.0,
        "floatTurnoverThreshold": 1.0
      }
    },
    "signalCategories": {
      "corporateTransformation": {
        "name": "Corporate Transformation & Strategic Pivots",
        "description": "Business model changes and transformational events - highest impact signals",
        "weight": 0.3,
        "priority": 1,
        "signals": {
          "defensePivotCatalyst": {
            "id": "CORP_001",
            "name": "Defense/Government Transformation",
            "description": "Pivot to defense sector - NUKK pattern (5535% surge)",
            "weight": 0.4,
            "dataRequired": [
              "sectorChange",
              "defenseAcquisitions",
              "governmentContracts"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "defense sector acquisition OR government contract award > $10M",
                "score": 75,
                "description": "Initial defense sector entry"
              },
              "trigger2": {
                "condition": "defense acquisition > marketCap * 0.5 OR Iron Dome/critical infrastructure",
                "score": 95,
                "description": "Transformational defense pivot - NUKK pattern"
              },
              "trigger3": {
                "condition": "NATO/DOD approved vendor status OR $100M+ government contracts",
                "score": 100,
                "description": "Full defense sector validation"
              }
            },
            "historicalExamples": {
              "NUKK": "5535% surge after Iron Dome supplier acquisition",
              "successRate": "80%+ for legitimate defense transformations"
            }
          },
          "biotechPivotPattern": {
            "id": "CORP_002",
            "name": "Biotech/AI Transformation Catalyst",
            "description": "High-multiple sector pivot opportunities",
            "weight": 0.35,
            "dataRequired": [
              "sectorChange",
              "acquisitionSize",
              "technologyPlatform"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "biotech/AI acquisition OR licensing deal > marketCap * 0.3",
                "score": 70,
                "description": "Significant high-tech transformation"
              },
              "trigger2": {
                "condition": "FDA-approved platform OR breakthrough AI technology",
                "score": 90,
                "description": "Validated technology transformation"
              }
            }
          },
          "reverseSplitAmplification": {
            "id": "CORP_003",
            "name": "Float Compression Mechanics",
            "description": "Reverse split creating volatility amplification - NUKK/HSDT pattern",
            "weight": 0.25,
            "dataRequired": [
              "reverseSplitRatio",
              "postSplitFloat",
              "upcomingCatalysts"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "reverse split ratio >= 8:1 AND post-split float < 10M shares",
                "score": 60,
                "description": "Significant float compression"
              },
              "trigger2": {
                "condition": "reverse split AND catalyst within 90 days AND float < 5M",
                "score": 85,
                "description": "NUKK-style volatility amplification setup"
              }
            },
            "mechanicsNote": "NUKK 1-for-8 split + RIMON acquisition = 5535% surge"
          }
        }
      },
      "clinicalAndRegulatory": {
        "name": "Clinical Excellence & Regulatory Milestones",
        "description": "FDA approvals, clinical superiority, and regulatory catalysts",
        "weight": 0.25,
        "priority": 1,
        "signals": {
          "clinicalSuperiority": {
            "id": "CLIN_001",
            "name": "Head-to-Head Clinical Superiority",
            "description": "Beating established standard of care - SMMT pattern",
            "weight": 0.4,
            "dataRequired": [
              "clinicalResults",
              "comparatorDrug",
              "statisticalSignificance"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "statistically significant improvement vs standard of care",
                "score": 70,
                "description": "Clinical superiority demonstrated"
              },
              "trigger2": {
                "condition": "49%+ improvement vs Keytruda/Opdivo OR first-in-class approval",
                "score": 95,
                "description": "SMMT-level clinical breakthrough"
              }
            },
            "historicalExample": "SMMT: 49% improvement vs Keytruda = 583% surge"
          },
          "reimbursementTippingPoint": {
            "id": "CLIN_002",
            "name": "Reimbursement Critical Mass",
            "description": "3+ major payers approval - HSDT pattern (119% surge)",
            "weight": 0.35,
            "dataRequired": [
              "payerApprovals",
              "reimbursementAmounts",
              "coverageTimeline"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "2 major payers approve reimbursement (Anthem, Aetna, UHC, etc.)",
                "score": 60,
                "description": "Reimbursement momentum building"
              },
              "trigger2": {
                "condition": "3+ major payers approve reimbursement within 6 months",
                "score": 90,
                "description": "HSDT-style reimbursement tipping point"
              },
              "trigger3": {
                "condition": "CMS/Medicare approval OR national coverage determination",
                "score": 100,
                "description": "Universal coverage catalyst"
              }
            },
            "mechanicsNote": "HSDT surged 119% on 3rd payer approval (Aetna)"
          },
          "fdaFastTrackMomentum": {
            "id": "CLIN_003",
            "name": "FDA Accelerated Pathway Signals",
            "description": "Fast Track, Breakthrough, Orphan designations",
            "weight": 0.25,
            "dataRequired": [
              "fdaDesignations",
              "trialTimelines",
              "regulatoryMilestones"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "FDA Fast Track designation OR Breakthrough Therapy",
                "score": 65,
                "description": "Accelerated regulatory pathway"
              },
              "trigger2": {
                "condition": "Orphan Drug designation with market exclusivity",
                "score": 80,
                "description": "Protected market opportunity"
              }
            }
          }
        }
      },
      "technicalCompression": {
        "name": "Advanced Technical Pattern Recognition",
        "description": "Enhanced technical patterns based on DRUG surge analysis",
        "weight": 0.2,
        "priority": 2,
        "signals": {
          "extremeVolatilityCompression": {
            "id": "TECH_001",
            "name": "DRUG-Pattern Bollinger Squeeze",
            "description": "Bollinger Band compression >30 days - DRUG 2000% pattern",
            "weight": 0.4,
            "dataRequired": [
              "bollingerBandWidth",
              "compressionDuration",
              "historicalVolatility"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "Bollinger Band width <5th percentile for 30+ days",
                "score": 70,
                "description": "Significant volatility compression"
              },
              "trigger2": {
                "condition": "BB squeeze >45 days AND RSI <30 AND catalyst approaching",
                "score": 95,
                "description": "DRUG-level coiled spring with catalyst"
              }
            },
            "historicalExample": "DRUG: Extreme BB squeeze preceded 2000% surge"
          },
          "oversoldDivergenceRecovery": {
            "id": "TECH_002",
            "name": "Extended Oversold Recovery Pattern",
            "description": "RSI <30 with bullish divergence setup",
            "weight": 0.35,
            "dataRequired": [
              "rsi14",
              "macdDivergence",
              "priceAction",
              "volumeConfirmation"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "RSI <25 for 10+ days AND volume building",
                "score": 55,
                "description": "Extreme oversold with accumulation"
              },
              "trigger2": {
                "condition": "RSI bullish divergence AND MACD convergence AND catalyst proximity",
                "score": 85,
                "description": "Multi-indicator oversold reversal setup"
              }
            }
          },
          "baseFormationBreakout": {
            "id": "TECH_003",
            "name": "Extended Base Building Pattern",
            "description": "6+ month consolidation preceding breakout",
            "weight": 0.25,
            "dataRequired": [
              "consolidationDuration",
              "supportTests",
              "volumePattern"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "6+ month base building AND multiple support tests",
                "score": 50,
                "description": "Solid foundation established"
              },
              "trigger2": {
                "condition": "NUKK-style 6-month $1.30-$2.00 base AND tightening volume",
                "score": 75,
                "description": "Extended base with volume compression"
              }
            }
          }
        }
      },
      "volumeIntelligence": {
        "name": "Advanced Volume Pattern Analysis",
        "description": "Sophisticated volume patterns from successful surges",
        "weight": 0.15,
        "priority": 2,
        "signals": {
          "progressiveAccumulation": {
            "id": "VOL_001",
            "name": "30-Day Pre-Surge Volume Building",
            "description": "Volume accumulation pattern from DRUG analysis",
            "weight": 0.4,
            "dataRequired": [
              "volume",
              "avgVolume30d",
              "institutionalActivity"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "volume >2x average for 5+ days in 30-day window",
                "score": 60,
                "description": "Early accumulation pattern"
              },
              "trigger2": {
                "condition": "volume >3x average for 7+ days AND 13F filings increase",
                "score": 85,
                "description": "Confirmed institutional accumulation"
              }
            }
          },
          "surgeVolumeConfirmation": {
            "id": "VOL_002",
            "name": "Extreme Volume Explosion",
            "description": "VTAK-style volume surge (2,870% above average)",
            "weight": 0.35,
            "dataRequired": [
              "volume",
              "avgVolume",
              "floatTurnover"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "volume >10x average AND float turnover >50%",
                "score": 65,
                "description": "Significant volume surge"
              },
              "trigger2": {
                "condition": "volume >25x average AND float turnover >100%",
                "score": 90,
                "description": "VTAK-level volume explosion"
              }
            }
          },
          "darkPoolAccumulation": {
            "id": "VOL_003",
            "name": "Institutional Dark Pool Activity",
            "description": "Off-exchange volume indicating smart money",
            "weight": 0.25,
            "dataRequired": [
              "darkPoolRatio",
              "blockTrades",
              "institutionalFlow"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "dark pool ratio >35% for 5+ days",
                "score": 55,
                "description": "Institutional accumulation signal"
              }
            }
          }
        }
      },
      "commercialValidation": {
        "name": "Commercial Breakthrough Signals",
        "description": "First sales, partnerships, and validation milestones",
        "weight": 0.07,
        "priority": 3,
        "signals": {
          "firstCommercialMilestone": {
            "id": "COMM_001",
            "name": "First Sale/Partnership Validation",
            "description": "VTAK-pattern first commercial order (173% surge)",
            "weight": 0.5,
            "dataRequired": [
              "firstSale",
              "customerCredibility",
              "contractValue"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "first commercial sale from recognized institution",
                "score": 70,
                "description": "Initial commercial validation"
              },
              "trigger2": {
                "condition": "first sale from major hospital/university system",
                "score": 90,
                "description": "VTAK-style validation milestone"
              }
            },
            "historicalExample": "VTAK: First order from Swedish university hospital = 173% surge"
          },
          "insiderInvestmentSignal": {
            "id": "COMM_002",
            "name": "Massive Insider Investment",
            "description": "SMMT-pattern: $79M insider investment at market prices",
            "weight": 0.5,
            "dataRequired": [
              "insiderPurchases",
              "purchasePrice",
              "marketPrice"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "insider purchases >$10M at market price within 30 days",
                "score": 75,
                "description": "Significant insider confidence"
              },
              "trigger2": {
                "condition": "insider purchases >$50M at market price (SMMT-style)",
                "score": 95,
                "description": "SMMT-level insider conviction"
              }
            },
            "mechanicsNote": "SMMT executives invested $79M at $22.70 before 583% surge"
          }
        }
      },
      "microstructure": {
        "name": "Market Microstructure Amplifiers",
        "description": "Float dynamics and structural volatility factors",
        "weight": 0.03,
        "priority": 4,
        "signals": {
          "ultraLowFloatDynamics": {
            "id": "MICRO_001",
            "name": "NUKK-Style Float Scarcity",
            "description": "Ultra-low float creating explosive potential",
            "weight": 0.6,
            "dataRequired": [
              "floatShares",
              "institutionalOwnership",
              "insiderOwnership"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "float <3M shares AND market cap $5M-$50M",
                "score": 75,
                "description": "DRUG-level volatility setup"
              },
              "trigger2": {
                "condition": "float <2.5M shares AND recent reverse split",
                "score": 90,
                "description": "NUKK-level amplification potential"
              }
            }
          },
          "shortSqueezeAmplification": {
            "id": "MICRO_002",
            "name": "Short Interest Dynamics",
            "description": "Short covering amplification factors",
            "weight": 0.4,
            "dataRequired": [
              "shortInterest",
              "daysToCover",
              "borrowRate"
            ],
            "thresholds": {
              "trigger1": {
                "condition": "short interest >20% AND days to cover >3",
                "score": 55,
                "description": "Moderate squeeze potential"
              },
              "trigger2": {
                "condition": "short interest >50% AND limited borrows available",
                "score": 80,
                "description": "High squeeze probability"
              }
            }
          }
        }
      }
    },
    "compositeScoring": {
      "description": "Enhanced scoring based on successful surge patterns",
      "weightingSystem": {
        "corporateTransformation": 0.3,
        "clinicalAndRegulatory": 0.25,
        "technicalCompression": 0.2,
        "volumeIntelligence": 0.15,
        "commercialValidation": 0.07,
        "microstructure": 0.03
      },
      "alertThresholds": {
        "ultraCritical": {
          "minimumScore": 300,
          "description": "NUKK/DRUG-level setup",
          "requiredCategories": [
            "corporateTransformation",
            "technicalCompression",
            "volumeIntelligence"
          ],
          "expectedAccuracy": "75-85%",
          "historicalExamples": [
            "NUKK: 5535%",
            "DRUG: 2000%"
          ]
        },
        "critical": {
          "minimumScore": 250,
          "description": "VTAK/SMMT-level setup",
          "requiredCategories": [
            "clinicalAndRegulatory",
            "volumeIntelligence"
          ],
          "expectedAccuracy": "65-75%",
          "historicalExamples": [
            "SMMT: 583%",
            "VTAK: 173%"
          ]
        },
        "high": {
          "minimumScore": 200,
          "description": "HSDT-level opportunity",
          "expectedAccuracy": "50-65%",
          "historicalExamples": [
            "HSDT: 119%",
            "MNPR: 522%"
          ]
        }
      }
    },
    "patternMatchingLibrary": {
      "description": "Documented surge patterns for matching",
      "defenseTransformation": {
        "pattern": "NUKK-style defense pivot",
        "characteristics": [
          "Sector transformation to defense",
          "Microscopic float (<3M shares)",
          "Government/military connections",
          "Geopolitical tailwinds",
          "Reverse split amplification"
        ],
        "expectedReturn": "1000-5000%",
        "timeframe": "1-7 days",
        "riskLevel": "Extreme"
      },
      "biotechSuperiorityy": {
        "pattern": "SMMT-style clinical breakthrough",
        "characteristics": [
          "Head-to-head superiority vs SOC",
          "FDA fast track designation",
          "Massive insider investment",
          "Multiple positive readouts",
          "Large addressable market"
        ],
        "expectedReturn": "300-600%",
        "timeframe": "30-180 days",
        "riskLevel": "High"
      },
      "technicalExplosion": {
        "pattern": "DRUG-style compression breakout",
        "characteristics": [
          "Bollinger Band squeeze >30 days",
          "Ultra-low float (<5M shares)",
          "30-day volume accumulation",
          "RSI bullish divergence",
          "Catalyst approaching"
        ],
        "expectedReturn": "500-2000%",
        "timeframe": "1-14 days",
        "riskLevel": "Extreme"
      },
      "commercialValidation": {
        "pattern": "VTAK-style first sale",
        "characteristics": [
          "First commercial order",
          "Credible customer",
          "Oversold technical setup",
          "Low float micro-cap",
          "Volume explosion confirmation"
        ],
        "expectedReturn": "100-300%",
        "timeframe": "1-3 days",
        "riskLevel": "High"
      }
    },
    "riskManagement": {
      "description": "Enhanced risk controls based on surge analysis",
      "positionSizing": {
        "ultraCritical": "1.0-2.5% per position",
        "critical": "0.5-1.5% per position",
        "high": "0.25-1.0% per position",
        "maxPortfolioAllocation": "12% total surge candidates"
      },
      "stopLossStrategy": {
        "technicalStops": "15-25% below entry",
        "timeStops": "Exit if no movement within 30 days",
        "catalystStops": "Exit immediately if catalyst fails"
      },
      "profitTaking": {
        "stage1": "25% at +100%",
        "stage2": "35% at +300%",
        "stage3": "25% at +700%",
        "runner": "15% with trailing stop"
      }
    },
    "implementationEnhancements": {
      "realTimeMonitoring": {
        "scanningFrequency": "Real-time with 15-second updates during market hours",
        "dataFeeds": [
          "SEC filings (8-K, 13G/D)",
          "Press releases",
          "FDA databases",
          "Clinical trial registries",
          "Insider transaction feeds",
          "Options flow data",
          "Social sentiment APIs"
        ]
      },
      "alertPrioritization": {
        "level1": "Defense transformation + float <3M",
        "level2": "Clinical superiority + insider investment >$10M",
        "level3": "BB squeeze >30 days + volume accumulation",
        "level4": "Reimbursement tipping point + oversold setup"
      }
    },
    "backtestingValidation": {
      "documentedSuccesses": {
        "NUKK": {
          "signals": [
            "defense pivot",
            "ultra-low float",
            "reverse split",
            "oversold bounce"
          ],
          "score": "9.3/10",
          "surge": "5535%",
          "accuracy": "Excellent"
        },
        "DRUG": {
          "signals": [
            "bollinger squeeze",
            "volume accumulation",
            "ultra-low float",
            "RSI divergence"
          ],
          "score": "9.1/10",
          "surge": "2000%",
          "accuracy": "Excellent"
        },
        "SMMT": {
          "signals": [
            "clinical superiority",
            "insider investment",
            "FDA fast track"
          ],
          "score": "8.8/10",
          "surge": "583%",
          "accuracy": "Excellent"
        },
        "VTAK": {
          "signals": [
            "first commercial sale",
            "oversold setup",
            "volume explosion"
          ],
          "score": "8.5/10",
          "surge": "173%",
          "accuracy": "Very Good"
        }
      },
      "projectedPerformance": {
        "overallAccuracy": "65-72%",
        "falsePositiveRate": "10-12%",
        "averageLeadTime": "3-7 days",
        "expectedSharpeRatio": 4.2
      }
    }
  }
}